Ferguson James J. III 4
4 · Matinas BioPharma Holdings, Inc. · Filed Dec 15, 2021
Insider Transaction Report
Form 4
Ferguson James J. III
Chief Medical Officer
Transactions
- Award
Stock Option (right to Buy)
2021-12-14+587,600→ 587,600 totalExercise: $0.92Exp: 2031-12-13→ Common Stock (587,600 underlying)
Footnotes (1)
- [F1]The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan. The option vests as to 25% of the shares on December 14, 2022 with the remaining shares to vest in equal monthly installments on the last day of each month over a period of 36 months commencing December 31, 2022.